146 related articles for article (PubMed ID: 1717129)
1. Nodular hepatocellular carcinoma. Treatment with subsegmental intraarterial injection of iodine 131-labeled iodized oil.
Yoo HS; Lee JT; Kim KW; Kim BS; Choi HJ; Lee KS; Park CI; Park CY; Suh JH; Loh JJ
Cancer; 1991 Nov; 68(9):1878-84. PubMed ID: 1717129
[TBL] [Abstract][Full Text] [Related]
2. Nodular hepatocellular carcinoma--treatment with intraarterial injection of I-131 Lipiodol.
Yoo HS; Suh JH; Lee JT; Kim KW; Kim DI; Kim BS; Choi HJ; Lee KS
J Korean Med Sci; 1990 Jun; 5(2):75-83. PubMed ID: 2177607
[TBL] [Abstract][Full Text] [Related]
3. Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma.
Leung WT; Lau WY; Ho S; Chan M; Leung N; Lin J; Ho KC; Metreweli C; Johnson PJ; Li AK
J Nucl Med; 1994 Aug; 35(8):1313-8. PubMed ID: 7519259
[TBL] [Abstract][Full Text] [Related]
4. Small hepatocellular carcinoma: high dose internal radiation therapy with superselective intra-arterial injection of I-131-labeled Lipiodol.
Yoo HS; Park CH; Lee JT; Kim KW; Yoon CS; Suh JH; Park CY; Kim BS; Choi HJ; Lee KS
Cancer Chemother Pharmacol; 1994; 33 Suppl():S128-33. PubMed ID: 8137473
[TBL] [Abstract][Full Text] [Related]
5. Iodine-131-Lipiodol for hepatocellular carcinoma: the benefits of targeting.
Novell JR; Hilson AJ
J Nucl Med; 1994 Aug; 35(8):1318-20. PubMed ID: 8046486
[No Abstract] [Full Text] [Related]
6. The anti-tumoral activity of neoadjuvant intra-arterial 131I-lipiodol treatment for hepatocellular carcinoma: a pilot study.
Brans B; De Winter F; Defreyne L; Troisi R; Vanlangenhove P; Van Vlierberghe H; Lambert B; Praet M; de Hemptinne B; Dierckx RA
Cancer Biother Radiopharm; 2001 Aug; 16(4):333-8. PubMed ID: 11603004
[TBL] [Abstract][Full Text] [Related]
7. Epirubicin-Lipiodol chemotherapy versus 131iodine-Lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma.
Bhattacharya S; Novell JR; Dusheiko GM; Hilson AJ; Dick R; Hobbs KE
Cancer; 1995 Dec; 76(11):2202-10. PubMed ID: 8635022
[TBL] [Abstract][Full Text] [Related]
8. 131I thyroid uptake in patients treated with 131I-Lipiodol for hepatocellular carcinoma.
Toubeau M; Touzery C; Berriolo-Riedinger A; Cochet A; Brunotte F; Bedenne L; Cercueil JP; Krause D
Eur J Nucl Med; 2001 May; 28(5):669-70. PubMed ID: 11383874
[No Abstract] [Full Text] [Related]
9. Internal radiation therapy for hepatocellular carcinoma. Results of a French multicenter phase II trial of transarterial injection of iodine 131-labeled Lipiodol.
Raoul JI; Bretagne JF; Caucanas JP; Pariente EA; Boyer J; Paris JC; Michel H; Bourguet P; Victor G; Therain F
Cancer; 1992 Jan; 69(2):346-52. PubMed ID: 1309429
[TBL] [Abstract][Full Text] [Related]
10. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support.
Raoul JL; Guyader D; Bretagne JF; Duvauferrier R; Bourguet P; Bekhechi D; Deugnier YM; Gosselin M
J Nucl Med; 1994 Nov; 35(11):1782-7. PubMed ID: 7525901
[TBL] [Abstract][Full Text] [Related]
11. Hepatic artery injection of I-131-labeled lipiodol. Part II. Preliminary results of therapeutic use in patients with hepatocellular carcinoma and liver metastases.
Bretagne JF; Raoul JL; Bourguet P; Duvauferrier R; Deugnier Y; Faroux R; Ramée A; Herry JY; Gastard J
Radiology; 1988 Aug; 168(2):547-50. PubMed ID: 2839867
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hepatocellular carcinoma by transcatheter hepatic arterial injection of radioactive iodized oil solution.
Yumoto Y; Jinno K; Inatsuki S; Moriwaki S; Hanafusa T; Yumoto E; Shiota T; Higashi T; Koide N; Hada H
Cancer Chemother Pharmacol; 1992; 31 Suppl():S128-36. PubMed ID: 1281043
[TBL] [Abstract][Full Text] [Related]
13. Intra-arterial iodine 131-labeled lipiodol as adjuvant therapy after curative liver resection for hepatocellular carcinoma: a phase 2 clinical study.
Partensky C; Sassolas G; Henry L; Paliard P; Maddern GJ
Arch Surg; 2000 Nov; 135(11):1298-300. PubMed ID: 11074884
[TBL] [Abstract][Full Text] [Related]
14. Intraarterial HCC therapy with I-131-Lipiodol.
Risse JH; Grünwald F; Kersjes W; Strunk H; Caselmann WH; Palmedo H; Bender H; Biersack HJ
Cancer Biother Radiopharm; 2000 Feb; 15(1):65-70. PubMed ID: 10740654
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma; treatment with a radioiodinated fatty acid ester.
Yoo HS; Park CH; Suh JH; Lee JT; Kim DI; Kim BS; Choi HJ; Madsen MT
Yonsei Med J; 1988; 29(2):166-75. PubMed ID: 2851226
[No Abstract] [Full Text] [Related]
16. Treatment of hepatocellular carcinoma (HCC) with radiolabeled Lipiodol: a preliminary report.
Park CH; Suh JH; Yoo HS; Lee JT; Kim DI; Kim BS
Nucl Med Commun; 1987 Dec; 8(12):1075-87. PubMed ID: 2835716
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival.
Lau WY; Lai EC; Leung TW; Yu SC
Ann Surg; 2008 Jan; 247(1):43-8. PubMed ID: 18156922
[TBL] [Abstract][Full Text] [Related]
18. [How I treat... An hepatocellular carcinoma: role of selective internal radiation therapy with intra-arterial iodine-131].
Werenne X
Rev Med Liege; 2007 Oct; 62(10):603-6. PubMed ID: 18069570
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma with skeletal metastasis: management with intraarterial radioactive iodine.
Cho YD; Yum HY; Park YH
J Belge Radiol; 1989 Aug; 72(4):267-71. PubMed ID: 2551883
[TBL] [Abstract][Full Text] [Related]
20. Following a trial that stopped early: what next for adjuvant hepatic intra-arterial iodine-131 lipiodol in resectable hepatocellular carcinoma?
Tan SB; Machin D; Cheung YB; Chung YF; Tai BC; Machin D
J Clin Oncol; 2002 Mar; 20(6):1709. PubMed ID: 11896125
[No Abstract] [Full Text] [Related]
[Next] [New Search]